 |
114 Diseases |  |
151 Trials |
|
151 Trials |  |
5480 News |  |
| «12...156157158159160161162163164165166167168» |
- doxycycline / Generic mfg.
Trial primary completion date: Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population (clinicaltrials.gov) - Jan 7, 2015
P2, N=40, Recruiting, Sponsor: Ottawa Hospital Research Institute
Trial primary completion date: Feb 2012 --> Jun 2016
- doxycycline / Generic mfg.
Enrollment closed, Trial primary completion date: Safety and Effect of Doxycycline in Patients With Amyloidosis (clinicaltrials.gov) - Jan 5, 2015
P2, N=60, Active, not recruiting, Sponsor: Boston University
Trial primary completion date: Feb 2012 --> Jun 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Jun 2015
- ceftriaxone / Generic mfg., doxycycline / Generic mfg., paracetamol / Generic mfg.
Clinical: Aseptic Meningoencephalitis in Slovenia (clinicaltrials.gov) - Jan 2, 2015
P=N/A, N=800, Recruiting, Sponsor: University Medical Centre Ljubljana
- doxycycline / Generic mfg., ursodeoxycholic acid / Generic mfg.
Enrollment closed, Trial primary completion date: Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis (clinicaltrials.gov) - Dec 19, 2014
P2, N=30, Active, not recruiting, Sponsor: Umeå University
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Jun 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Jun 2015
- Tetralysal (lymecycline) / Galderma
Trial primary completion date: Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced (clinicaltrials.gov) - Dec 17, 2014
P4, N=160, Recruiting, Sponsor: Ostergotland County Council, Sweden
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Jun 2015 Trial primary completion date: Jan 2013 --> Aug 2015
- || doxycycline / Generic mfg.
Trial completion, Trial primary completion date: Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis (clinicaltrials.gov) - Dec 17, 2014
P3, N=30, Completed, Sponsor: CD Pharma India Pvt. Ltd.
Trial primary completion date: Jan 2013 --> Aug 2015 Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Nov 2014
- phenoxymethylpenicillin / Generic mfg., doxycycline / Generic mfg., amoxicillin / Generic mfg.
Trial completion: NorTick_EM: Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice (clinicaltrials.gov) - Dec 13, 2014
P4, N=225, Completed, Sponsor: Morten Lindbaek
Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Nov 2014 Active, not recruiting --> Completed
- doxycycline / Generic mfg.
Trial primary completion date, Surgery: DOXYPOSTOP: Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial (clinicaltrials.gov) - Dec 7, 2014
P2, N=80, Recruiting, Sponsor: University Hospital, Ghent
Active, not recruiting --> Completed Trial primary completion date: Oct 2013 --> Oct 2015
- doxycycline / Generic mfg.
Trial termination: Study About the Effect of Doxycycline and Acetylcystein in the Treatment of CD-associated Fistulae (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=20, Terminated, Sponsor: Gerhard Rogler
Trial primary completion date: Oct 2013 --> Oct 2015 Recruiting --> Terminated; not enough patients enrolled
- Trial primary completion date: The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) (clinicaltrials.gov) - Dec 5, 2014
P2, N=250, Recruiting, Sponsor: Harold Wiesenfeld
Recruiting --> Terminated; not enough patients enrolled Trial primary completion date: Aug 2014 --> Mar 2015
- || doxycycline / Generic mfg.
New P3 trial: Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD Patients (clinicaltrials.gov) - Dec 5, 2014
P3, N=222, Recruiting, Sponsor: Imperial College London
- || Vizimpro (dacomitinib) / Pfizer
Trial primary completion date, Adverse events, Patient reported outcomes, Metastases: ARCHER 1042: Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO (clinicaltrials.gov) - Nov 24, 2014
P2, N=184, Recruiting, Sponsor: Pfizer
Trial primary completion date: Aug 2014 --> Mar 2015 Trial primary completion date: Oct 2014 --> Feb 2015
- | doxycycline / Generic mfg.
Enrollment closed: Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis (clinicaltrials.gov) - Nov 13, 2014
P3, N=30, Active, not recruiting, Sponsor: CD Pharma India Pvt. Ltd.
Trial primary completion date: Oct 2014 --> Feb 2015 Recruiting --> Active, not recruiting
- doxycycline / Generic mfg.
Enrollment open: KL2TR001438: Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial (clinicaltrials.gov) - Nov 12, 2014
P2, N=30, Recruiting, Sponsor: Medical College of Wisconsin
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Enrollment open: Use of the Ulcerative Colitis Diet for Induction of Remission (clinicaltrials.gov) - Nov 6, 2014
P=N/A, N=20, Recruiting, Sponsor: Prof. Arie Levine
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- doxycycline / Generic mfg., tetracycline / Generic mfg.
Trial primary completion date: The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment (clinicaltrials.gov) - Nov 5, 2014
P4, N=180, Recruiting, Sponsor: Radboud University
Not yet recruiting --> Recruiting Trial primary completion date: Sep 2014 --> Sep 2015
- | doxycycline / Generic mfg.
New P2 trial: Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana (clinicaltrials.gov) - Nov 3, 2014
P2, N=200, Not yet recruiting, Sponsor: Kwame Nkrumah University of Science and Technology
- doxycycline / Generic mfg.
Clinical: DPMSM: Efficacy of Doxycycline Prophylaxis to Reduce Syphilis in High-Risk, HIV-Positive MSM (clinicaltrials.gov) - Oct 11, 2014
P=N/A, N=30, Completed, Sponsor: Los Angeles LGBT Center
- ||||| Erbitux (cetuximab) / Eli Lilly, EMD Serono, Vectibix (panitumumab) / Amgen, Takeda
New P2 trial, Metastases: Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab (clinicaltrials.gov) - Oct 10, 2014
P2, N=80, Active, not recruiting, Sponsor: Mayo Clinic
- | doxycycline / Generic mfg.
Enrollment open, Trial primary completion date: Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA) (clinicaltrials.gov) - Oct 10, 2014
P2/3, N=286, Recruiting, Sponsor: Paul Yates, MD, PhD
Trial primary completion date: Sep 2014 --> Sep 2015 Not yet recruiting --> Recruiting | Trial primary completion date: Mar 2017 --> Jul 2017
- doxycycline / Generic mfg., voriconazole / Generic mfg.
Phase classification: A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity (clinicaltrials.gov) - Oct 2, 2014
P1, N=62, Completed, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting | Trial primary completion date: Mar 2017 --> Jul 2017 Phase classification: P=N/A --> P1
- | Erbitux (cetuximab) / Eli Lilly, EMD Serono, Vectibix (panitumumab) / Amgen, Takeda
New P2 trial: Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients (clinicaltrials.gov) - Sep 15, 2014
P2, N=24, Not yet recruiting, Sponsor: Foamix Ltd.
- doxycycline / Generic mfg.
Trial primary completion date: MI-PCOS: Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome (clinicaltrials.gov) - Sep 4, 2014
P3, N=40, Recruiting, Sponsor: University of Rochester
Phase classification: P=N/A --> P1 Trial primary completion date: Jun 2014 --> Jan 2015
- | doxycycline / Generic mfg.
Enrollment open: Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis (clinicaltrials.gov) - Sep 4, 2014
P3, N=30, Recruiting, Sponsor: CD Pharma India Pvt. Ltd.
Trial primary completion date: Jun 2014 --> Jan 2015 Not yet recruiting --> Recruiting
- doxycycline / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: DOXY-HF: Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy (clinicaltrials.gov) - Aug 21, 2014
P2, N=10, Terminated, Sponsor: Virginia Commonwealth University
Not yet recruiting --> Recruiting N=24 --> 10 | Recruiting --> Terminated | Trial primary completion date: Dec 2014 --> Jun 2014; End of funding
- || doxycycline / Generic mfg.
Biomarker, New P3 trial: Diagnostic Biomarkers Related to Periodontal Disease Activity in Diabetic (clinicaltrials.gov) - Aug 21, 2014
P3, N=56, Completed, Sponsor: University of Sao Paulo
- doxycycline / Generic mfg.
Enrollment closed: Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial Matrix Metalloproteinases (clinicaltrials.gov) - Aug 19, 2014
P=N/A, N=14, Active, not recruiting, Sponsor: University of Hawaii
N=24 --> 10 | Recruiting --> Terminated | Trial primary completion date: Dec 2014 --> Jun 2014; End of funding Recruiting --> Active, not recruiting
- Clinical: Use of the Ulcerative Colitis Diet for Induction of Remission (clinicaltrials.gov) - Aug 15, 2014
P=N/A, N=20, Not yet recruiting, Sponsor: Prof. Arie Levine
- |||| doxycycline / Generic mfg.
Trial completion: Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo (clinicaltrials.gov) - Aug 4, 2014
P4, N=235, Completed, Sponsor: Galderma Laboratories, L.P.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- doxycycline / Generic mfg.
New P2 trial: KL2TR001438: Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial (clinicaltrials.gov) - Aug 4, 2014
P2, N=30, Not yet recruiting, Sponsor: Medical College of Wisconsin
- |||| doxycycline / Generic mfg.
Trial completion: A Clinical Trial of YH14642 in Patients With Chronic Periodontal Disease (clinicaltrials.gov) - Aug 1, 2014
P2, N=162, Completed, Sponsor: Yuhan Corporation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- doxycycline / Generic mfg.
Clinical: RosaC-RF : Bipolar Radiofrequency vs Doxycycline in Rosacea (clinicaltrials.gov) - Jul 30, 2014
P=N/A, N=40, Recruiting, Sponsor: Centre Hospitalier Universitaire de Nice
- doxycycline / Generic mfg.
New P2 trial: Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy (clinicaltrials.gov) - Jul 30, 2014
P2, N=20, Recruiting, Sponsor: Sun Yat-sen University
- atorvastatin / Generic mfg., mebendazole / Generic mfg., doxycycline / Generic mfg.
Real-world evidence, Real-world: METRICS: Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer (clinicaltrials.gov) - Jul 28, 2014
P=N/A, N=2000, Recruiting, Sponsor: Health Clinics Limited
- doxycycline / Generic mfg.
Trial completion, Enrollment change: Comparison Between aPDT and Systemic Doxycycline on Non-surgical Periodontal Therapy in Type 2 Diabetics (clinicaltrials.gov) - Jul 16, 2014
P3, N=30, Completed, Sponsor: University of Sao Paulo
Active, not recruiting --> Completed Recruiting --> Completed | N=40 --> 30
- Vectibix (panitumumab) / Amgen
Trial primary completion date, Metastases: SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity Treatment (clinicaltrials.gov) - Jul 14, 2014
P2, N=11, Terminated, Sponsor: Gesellschaft fur Medizinische Innovation
Recruiting --> Completed | N=40 --> 30 Trial primary completion date: Feb 2014 --> May 2013
- Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%) / Novartis
Enrollment change: Manipulating the Microbiome in IBD by Antibiotics and FMT (clinicaltrials.gov) - Jul 8, 2014
P4, N=28, Recruiting, Sponsor: Shaare Zedek Medical Center
Trial primary completion date: Feb 2014 --> May 2013 N=20 --> 28
- ||| doxycycline / Generic mfg.
New P3 trial: Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis (clinicaltrials.gov) - Jun 27, 2014
P3, N=30, Not yet recruiting, Sponsor: CD Pharma India Pvt. Ltd.
- doxycycline / Generic mfg.
New P2 trial: Properties of Glass Ionomer Cements Associated With Chlorhexidine or Doxycycline (clinicaltrials.gov) - Jun 22, 2014
P2, N=18, Completed, Sponsor: Aline R F de Castilho
- doxycycline / Generic mfg., azithromycin / Generic mfg.
Trial primary completion date: Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities (clinicaltrials.gov) - Jun 17, 2014
P3, N=567, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=20 --> 28 Trial primary completion date: Jan 2014 --> May 2014
- | doxycycline / Generic mfg., azithromycin / Generic mfg.
Trial completion: Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities (clinicaltrials.gov) - Jun 17, 2014
P3, N=567, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Jan 2014 --> May 2014 Recruiting --> Completed
- | doxycycline / Generic mfg., azithromycin / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities (clinicaltrials.gov) - Jun 11, 2014
P3, N=380, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed N=575 --> 380 | Recruiting --> Completed | Trial primary completion date: Jan 2014 --> May 2014
- doxycycline / Generic mfg.
Enrollment open: A Phase II Study of Doxycycline in Relapsed NHL (clinicaltrials.gov) - May 28, 2014
P2, N=20, Recruiting, Sponsor: University of Rochester
N=575 --> 380 | Recruiting --> Completed | Trial primary completion date: Jan 2014 --> May 2014 Not yet recruiting --> Recruiting
- doxycycline / Generic mfg.
Trial initiation date: Doxycycline for COPD in HIV-Infected Patients (clinicaltrials.gov) - May 26, 2014
P=N/A, N=30, Recruiting, Sponsor: Weill Medical College of Cornell University
Not yet recruiting --> Recruiting Initiation date: Jan 2013 --> Jan 2014
- doxycycline / Generic mfg.
Enrollment open: Doxycycline for COPD in HIV-Infected Patients (clinicaltrials.gov) - May 26, 2014
P=N/A, N=30, Recruiting, Sponsor: Weill Medical College of Cornell University
Initiation date: Jan 2013 --> Jan 2014 Not yet recruiting --> Recruiting
- doxycycline / Generic mfg.
Clinical: Laboratory Characteristics in Chronic Atrophic Acrodermatitis (clinicaltrials.gov) - May 22, 2014
P=N/A, N=50, Recruiting, Sponsor: University Medical Centre Ljubljana
- doxycycline / Generic mfg.
Clinical: Cytokines and Chemokines in Erythema Migrans (clinicaltrials.gov) - May 22, 2014
P=N/A, N=150, Recruiting, Sponsor: University Medical Centre Ljubljana
- Erbitux (cetuximab) / Eli Lilly, EMD Serono, Vectibix (panitumumab) / Amgen, Takeda
Trial primary completion date, Metastases: Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab (clinicaltrials.gov) - May 20, 2014
P2, N=80, Recruiting, Sponsor: Academic and Community Cancer Research United
Not yet recruiting --> Recruiting Trial primary completion date: Apr 2015 --> Aug 2014
- ceftriaxone / Generic mfg., doxycycline / Generic mfg.
Trial primary completion date: Antibiotic Treatment of Multiple Erythema Migrans (clinicaltrials.gov) - May 20, 2014
P=N/A, N=720, Recruiting, Sponsor: University Medical Centre Ljubljana
Trial primary completion date: Apr 2015 --> Aug 2014 Trial primary completion date: Oct 2013 --> Oct 2015
- New P4 trial: C H R O N O S: Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis (clinicaltrials.gov) - Apr 14, 2014
P4, N=40, Completed, Sponsor: Tourcoing Hospital